| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 207,239 | 151,514 | 129,608 | 100,224 | | Cost of Revenue | 194,612 | 118,898 | 109,894 | 76,521 | | | Gross Profit | 12,627 | 32,616 | 19,714 | 23,703 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 45,801 | 38,975 | 36,360 | 38,862 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (33,174) | (6,359) | (16,646) | (15,159) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (33,174) | (6,359) | (16,646) | (15,159) | | Interest Expense | 2,848 | 3,380 | 3,774 | 4,062 | | Income Before Tax | (36,022) | (9,739) | (20,420) | (19,221) | | Income Tax Expense | (3,039) | (559) | (151) | (4,881) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,983) | (9,180) | (20,269) | (14,340) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,983) | (9,180) | (20,269) | (14,340) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,983) | ($9,180) | ($20,269) | ($14,340) |
|
1.52% Nasdaq 0.00%
Income Statement
